Promal Methallylescaline 21 MG Pellets

PRODUCT DESCRIPTION

Introduction

Promal Methallylescaline is a synthetic psychedelic compound belonging to the phenethylamine class, chemically known as 4-methallyloxy-3,5-dimethoxyphenethylamine. It is a methylated analog of allylescaline, first synthesized by Alexander Shulgin and described in his book PiHKAL. Methallylescaline produces psychedelic effects with visual phenomena such as neon colors and kaleidoscopic imagery. This compound is provided in 21 mg pellets designed for research purposes to explore its pharmacology, neurochemical effects, and psychotropic profile.

Chemical Properties and Specifications

Structural and Molecular Characteristics

• Chemical Formula: C14H21NO3C14H21NO3

• Molecular Weight: 251.32 g/mol

• CAS Number: 207740-41-8

• IUPAC Name: 4-methallyloxy-3,5-dimethoxyphenethylamine

• Synonyms: Methallylescaline, MAL, 4-methylallyloxy-3,5-dimethoxyphenethylamine

Physical Properties and Purity Standards

• Appearance: White crystalline or pellet form (21 mg dosage per pellet)

• Purity: Typically ≥98% pure for research-grade compound

• Solubility: Moderate solubility in aqueous and organic solvents

• Storage Recommendations: Store in airtight containers in a cool, dry, dark place to maintain chemical stability and potency

Pharmacological Profile and Mechanism of Action

Proposed Mechanism of Action

Methallylescaline is believed to act as a partial agonist at serotonin 5-HT2A receptors, similar to other psychedelic phenethylamines. The psychedelic experience is due to its modulation of this receptor resulting in altered perception, cognition, and mood. However, its detailed pharmacodynamics and metabolic pathways remain largely undocumented and require further research.

Research Applications

Used primarily in psychopharmacology for studying serotonin receptor-mediated psychedelic effects, neural mechanisms of consciousness, and structure-activity relationships within the substituted phenethylamine family.

Comparative Analysis with Related Compounds

Compare to Related Compounds

Methallylescaline is structurally closely related to allylescaline but has a methyl group at the allyloxy substitution. It shares similar psychedelic effects and duration (8-12 hours) but is generally considered less potent than allylescaline. Compared to mescaline, it produces stronger visuals and longer duration.

Advantages for Research

Its unique substitution pattern allows exploration of structure-activity relationships and receptor specificity in phenethylamine psychedelics, advancing understanding of serotonin receptor pharmacology.

Safety and Handling Guidelines

Laboratory Safety

Wear gloves and eye protection when handling. Avoid inhalation, ingestion, or skin contact. Conduct research in controlled laboratory environments.

Disposal and Environmental Considerations

Dispose of chemicals and contaminated materials according to hazardous chemical waste regulations.

Regulatory Status

Promal Methallylescaline is a research chemical, not approved for human consumption, and regulated under relevant chemical and narcotics research laws.

Frequently Asked Questions (FAQs)

1. What is the typical dose of Promal Methallylescaline?
   Around 21 mg per pellet, with research doses ranging typically from 40-60 mg orally.

2. What effects does Methallylescaline produce?
   Psychedelic effects including strong visual hallucinations and altered perception.

3. How is it stored?
   In airtight containers, cool and dark conditions.

4. Is it potent compared to mescaline?
   It is more potent and longer lasting than mescaline.

5. Are there known risks?
   Limited data on toxicity; use with appropriate research precautions.

Conclusion

Promal Methallylescaline 21 MG pellets are high-purity psychedelic phenethylamine research chemicals. Their controlled dosage and unique chemical structure facilitate advanced psychopharmacological studies into serotonergic psychedelics and consciousness.